Compounded tirzepatide
Sold by Aurelius Health Group · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
Recorded initial charges
First month
$89
Published monthly rate
$199
first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.
| Medication · Microdose GLP-1 Protocol · recorded initial monthly payment | $89 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Microdose GLP-1 Protocol “Microdose GLP-1 Protocol $89 first month then $199/month Cancel anytime before next billing cycle. No hidden fees.” | Per month$199 | Charged today$89 |
Price sources
- Microdose GLP-1 Protocol · aureliushealthgroup.com — read September 2026
We earn nothing from this link. It opens Aurelius Health Group's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | RedRock Pharmacy, St. George UT; Health Warehouse, Florence KY; Precision Compounding Pharmacy, Bellmore NY; Triad Rx, Daphne AL |
|---|---|
| Prescriber | Asynchronous review |
| Cancellation | Cancel for any reason. We require notice at least 72 hours before your next billing date. |
Not yet checked: states, membership and consult fee.
Recorded from aureliushealthgroup.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Site markets specifically 'Microdose GLP-1' using sub-therapeutic tirzepatide doses (its own outcome calculator is explicitly 'Based on observational data at 1mg microdose tirzepatide') rather than standard full-dose GLP-1 therapy — worth flagging since a reader searching for a standard-dose program would be misled. The comparison table's 'Standard Full Dose' column (2.4 mg/wk injectable, $200-$300+/mo) describes a competitor/reference product, not Aurelius's own offering. Treatment is compounded and shipped from a licensed U.S. pharmacy, but vial-vs-pen was never stated.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.